The 9th International Conference on Alzheimer's Disease Drug Discovery will bring together academic and industry scientists to accelerate the development of novel drug discovery programs for Alzheimer’s disease. 

It will offer updates on ongoing research, as well as highlight new studies and concepts.  >>>

- To discuss scientific progress on drug discovery programs aimed at treating Alzheimer’s disease and related dementias.

- To increase networking opportunities for scientists to share information and resources.

- To publish and distribute a post-meeting report in a peer-reviewed scientific journal.

This ADDF meeting is one of the few conferences that focuses exclusively on the development of innovative drugs targeting Alzheimer's disease and related dementias.  Click here to play Dr. Howard Fillit's recording of his welcome address.

Click here to review the winners of the 10 ADDF Young Investigator Scholarships!

Read about CME accreditation here.

I. Neuroprotection

II. Anti-Amyloid & Misfolding

III. Anti-Tangles & Frontotemporal Dementia

IV. Anti-Inflammatory & Anti-Oxidant Strategies  >>>

Early Bird Registration Deadline is September 1, 2008! 

Click here to review registration details.

The conference offers great opportunities to expand visibility among the registrants by becoming an exhibitor and/or conference sponsor.  Review the various sponsorship and exhibit packages available and contact Filomena Machleder, ADDF Partnership Relations Manager at +1-212-901-8004 or fmachleder@AlzDiscovery.org.

Review past editions of this conference as well as other relevant ADDF meetings.

Learn more about ADDF.